GTN0 Relative Valuation - Getinge AB

Watchlist Manager

Watchlist

Price: 17.5 EUR -1.13%

Market Cap: €4.4B

Relative Value

The Relative Value of one GTN0 stock under the Base Case scenario is 21.42 EUR. Compared to the current market price of 17.5 EUR, Getinge AB is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

GTN0 Relative Value

Base Case

Undervaluation 18%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
SE	Getinge AB F:GTN0	51.8B EUR	1.5	22.8	8.9	13.7
US	Abbott Laboratories NYSE:ABT	187.8B USD	4.2	28.8	16.5	22.7
US	Intuitive Surgical Inc NASDAQ:ISRG	170.2B USD	16.9	59.6	45.2	55.5
US	Stryker Corp NYSE:SYK	129B USD	5.1	39.7	20.3	24.5
IE	Medtronic PLC NYSE:MDT	112.1B USD	3.2	24.3	13.4	19.6
US	Boston Scientific Corp NYSE:BSX	101.7B USD	5.1	35.1	20.6	27.7
DE	Siemens Healthineers AG XETRA:SHL	43.8B EUR	1.9	20.8	11.6	16.3
US	Edwards Lifesciences Corp NYSE:EW	49.1B USD	8.1	45.8	25.2	27.6
US	IDEXX Laboratories Inc NASDAQ:IDXX	45.5B USD	10.6	43	30.6	33.8
US	Becton Dickinson and Co NYSE:BDX	45.5B USD	2.1	25.9	10.2	17.2
US	Resmed Inc NYSE:RMD	33.9B USD	6.3	22.8	16	17.8

			Revenue Growth	P/S to Growth
SE	Getinge AB F:GTN0	Average P/S: 5.9 1.5	4%	0.4
US	Abbott Laboratories NYSE:ABT	4.2	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	16.9	15%	1.1
US	Stryker Corp NYSE:SYK	5.1	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.2	7%	0.5
US	Boston Scientific Corp NYSE:BSX	5.1	11%	0.5
DE	Siemens Healthineers AG XETRA:SHL	1.9	5%	0.4
US	Edwards Lifesciences Corp NYSE:EW	8.1	11%	0.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	10.6	10%	1.1
US	Becton Dickinson and Co NYSE:BDX	2.1	-2%	N/A
US	Resmed Inc NYSE:RMD	6.3	8%	0.8

			Earnings Growth	PEG
SE	Getinge AB F:GTN0	Average P/E: 33.5 22.8	19%	1.2
US	Abbott Laboratories NYSE:ABT	28.8	23%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	59.6	19%	3.1
US	Stryker Corp NYSE:SYK	39.7	30%	1.3
IE	Medtronic PLC NYSE:MDT	24.3	22%	1.1
US	Boston Scientific Corp NYSE:BSX	35.1	31%	1.1
DE	Siemens Healthineers AG XETRA:SHL	20.8	16%	1.3
US	Edwards Lifesciences Corp NYSE:EW	45.8	27%	1.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	43	13%	3.3
US	Becton Dickinson and Co NYSE:BDX	25.9	35%	0.7
US	Resmed Inc NYSE:RMD	22.8	11%	2.1

			EBITDA Growth	EV/EBITDA to Growth
SE	Getinge AB F:GTN0	Average EV/EBITDA: 19.9 8.9	8%	1.1
US	Abbott Laboratories NYSE:ABT	16.5	11%	1.5
US	Intuitive Surgical Inc NASDAQ:ISRG	45.2	23%	2
US	Stryker Corp NYSE:SYK	20.3	12%	1.7
IE	Medtronic PLC NYSE:MDT	13.4	8%	1.7
US	Boston Scientific Corp NYSE:BSX	20.6	18%	1.1
DE	Siemens Healthineers AG XETRA:SHL	11.6	10%	1.2
US	Edwards Lifesciences Corp NYSE:EW	25.2	14%	1.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	30.6	11%	2.8
US	Becton Dickinson and Co NYSE:BDX	10.2	1%	10.2
US	Resmed Inc NYSE:RMD	16	11%	1.5

			EBIT Growth	EV/EBIT to Growth
SE	Getinge AB F:GTN0	Average EV/EBIT: 25.1 13.7	12%	1.1
US	Abbott Laboratories NYSE:ABT	22.7	18%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	55.5	25%	2.2
US	Stryker Corp NYSE:SYK	24.5	16%	1.5
IE	Medtronic PLC NYSE:MDT	19.6	17%	1.2
US	Boston Scientific Corp NYSE:BSX	27.7	26%	1.1
DE	Siemens Healthineers AG XETRA:SHL	16.3	15%	1.1
US	Edwards Lifesciences Corp NYSE:EW	27.6	15%	1.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	33.8	12%	2.8
US	Becton Dickinson and Co NYSE:BDX	17.2	15%	1.1
US	Resmed Inc NYSE:RMD	17.8	12%	1.5

Getinge AB
F:GTN0

Relative Value

Valuation Multiples

Multiples Across Competitors

GTN0 Competitors Multiples
Getinge AB Competitors

See Also

Company

Help

Tools

Stocks

Getinge AB F:GTN0

Relative Value

Valuation Multiples

Multiples Across Competitors

GTN0 Competitors Multiples Getinge AB Competitors

See Also

Company

Help

Tools

Stocks

Getinge AB
F:GTN0

GTN0 Competitors Multiples
Getinge AB Competitors